266 related articles for article (PubMed ID: 8827070)
21. The EWS-WT1 gene fusion in desmoplastic small round cell tumor.
Gerald WL; Haber DA
Semin Cancer Biol; 2005 Jun; 15(3):197-205. PubMed ID: 15826834
[TBL] [Abstract][Full Text] [Related]
22. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
23. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
[TBL] [Abstract][Full Text] [Related]
24. The role of Wilms' tumor genes.
Hirose M
J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
[TBL] [Abstract][Full Text] [Related]
25. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K
Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002
[TBL] [Abstract][Full Text] [Related]
27. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.
Ohno T; Ouchida M; Lee L; Gatalica Z; Rao VN; Reddy ES
Oncogene; 1994 Oct; 9(10):3087-97. PubMed ID: 8084618
[TBL] [Abstract][Full Text] [Related]
28. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct.
Kim J; Lee K; Pelletier J
Oncogene; 1998 Feb; 16(8):1021-30. PubMed ID: 9519876
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.
Gerald WL; Rosai J; Ladanyi M
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1028-32. PubMed ID: 7862627
[TBL] [Abstract][Full Text] [Related]
30. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
31. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein.
Finkeltov I; Kuhn S; Glaser T; Idelman G; Wright JJ; Roberts CT; Werner H
Oncogene; 2002 Mar; 21(12):1890-8. PubMed ID: 11896622
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays.
Schaefer KL; Wai DH; Poremba C; Korsching E; van Valen F; Ozaki T; Boecker W; Dockhorn-Dworniczak B
Virchows Arch; 2002 May; 440(5):476-84. PubMed ID: 12021921
[TBL] [Abstract][Full Text] [Related]
34. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
35. FUS/ERG gene fusions in Ewing's tumors.
Shing DC; McMullan DJ; Roberts P; Smith K; Chin SF; Nicholson J; Tillman RM; Ramani P; Cullinane C; Coleman N
Cancer Res; 2003 Aug; 63(15):4568-76. PubMed ID: 12907633
[TBL] [Abstract][Full Text] [Related]
36. Desmoplastic small round cell tumor: RT-PCR analysis and immunohistochemical detection of the Wilm's tumor gene WT1.
Barnoud R; Delattre O; Péoc'h M; Pasquier D; Plantaz D; Leroux D; Pasquier B
Pathol Res Pract; 1998; 194(10):693-700. PubMed ID: 9820865
[TBL] [Abstract][Full Text] [Related]
37. EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma.
Kaneko Y; Kobayashi H; Handa M; Satake N; Maseki N
Genes Chromosomes Cancer; 1997 Mar; 18(3):228-31. PubMed ID: 9071576
[TBL] [Abstract][Full Text] [Related]
38. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
Mrowka C; Schedl A
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
[TBL] [Abstract][Full Text] [Related]
39. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
